Journal of Endocrinological Investigation · Nov 16, 2026
Chromosome Y and X dosage in infertile men: associations with reproductive parameters and biological ageing
By Griseta V, Spaggiari G, Sperduti S et al.
Background Male infertility remains unexplained in up to 50% of cases despite conventional clinical and seminal evaluation. Mosaic loss of chromosome Y (LOY), the most common acquired chromosomal alteration in men, has emerged as a biomarker of genomic instability and biological ageing, but its potential role in male reproductive dysfunction remains poorly understood. This study investigated chromosome Y and X dosage in infertile men using droplet digital polymerase chain reaction (ddPCR). Methods In this prospective cohort study, chromosome Y and X dosage was quantified in peripheral-blood DNA using USP9Y/FSHR and AR/FSHR copy-number ratios. Estimated LOY and LOX percentages were derived from these ratios. Participants were compared within the cohort according to the WHO 6th edition semen reference values. Correlations with clinical, hormonal, testicular, and semen parameters were exploratory, univariate, and unadjusted for multiple testing. Results A total of 169 infertile men were enrolled, including 50 (29.6%) without seminal alterations and 119 (70.4%) with at least one abnormal seminal parameter. Neither the USP9Y/FSHR and AR/FSHR copy-number ratios nor the estimated percentages of LOY and LOX differed significantly between the two groups. Mean estimated LOY values remained close to the expected physiological range, indicating no evidence of overt LOY. Weak nominal correlations were observed between estimated LOY and age (ρ = 0.174, p = 0.024), total sperm number (ρ = -0.163, p = 0.034), and prolactin (ρ = -0.167, p = 0.032). Estimated LOX showed no consistent association with the evaluated parameters. Conclusions Overt sex-chromosome loss was not evident in this cohort and chromosome dosage did not distinguish infertile men with abnormal semen parameters from those with reference-range semen parameters. Because no fertile control group was included, the study cannot determine whether sex-chromosome dosage is associated with infertility itself. The weak, unadjusted correlations are exploratory and their clinical relevance is uncertain.